PharmiWeb

Populus Health Technologies Partners with Patients, Physicians and Pharma Marketers to Create the First Comprehensive Report on Virtual Care in America

The Princeton-based virtual care company partnered with DHC Group, PM360 and Researchscape to develop a comprehensive understanding of the benefits of virtual care in improving patient care and ...
PharmiWeb

Lomiko Metals Continues to Expand on Newly Discovered REE Anomalies at the Yellow Fox Critical Metals/REE Property Located in Central Newfoundland

Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko” or the “Company”) is pleased to announce results from additional REE analysis on 32 samples from the Phase II soil sampling program at the Yellow Fox Property ...
PharmiWeb

bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16

Invitation-only conference focuses on the evolving landscape of lung cancer risk and early detection when the disease is most treatablebioAffinity Technologies Chief Medical Officer Gordon Downie, MD, ...
PharmiWeb

Fortitude Biomedicines Announces Lead Program Targeting Disease-Driven T-cell Signaling Pathways for the Treatment of Axial Spondyloarthritis

Appointment of Dr. Rahul Patel as Senior Vice President of Clinical Development strengthens leadership team and provides critical support to accelerate clinical development of lead programWALTHAM, ...
PharmiWeb

AV’s UES Awarded $25M AFRL Contract to Mature Human Performance Technologies for Warfighter Readiness

The United States Air Force has awarded UES, a division of advanced research and development leader AeroVironment, Inc. (“AV”) (NASDAQ: AVAV), a three-year, $25M contract to transition innovative ...
PharmiWeb

Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing

Provides an automated, functionally closed approach to help address variability and support more reliable, consistent manufacturing outcomes  WALTHAM, Mass., April 2, 2026 — Thermo Fisher Scientific ...
PharmiWeb

Life Sciences Ontario Welcomes New Board Members in 2026 Following Annual General Meeting

Life Sciences Ontario (LSO) is pleased to announce the appointment of four distinguished leaders to its Board of Directors, following its Annual General Meeting on March 25, 2026.The newly appointed ...
PharmiWeb

Biocon Announces U.S. Commercial Launch of Bosaya™ and Aukelso™, Denosumab Biosimilars

Bosaya™ and Aukelso™ (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with an interchangeable designationPotential benefit to the ...
PharmiWeb

enGene Announces Name Change to enGene Therapeutics Inc.

Name change reflects transition towards potential commercial organization in 2027Planned Biologics License Application (BLA) submission for detalimogene in 2H 2026BOSTON & MONTREAL--(BUSINESS ...
PharmiWeb

Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion

Neuland Laboratories, a global contract development and manufacturing organization (CDMO) specialising in complex APIs, has today announced a leadership change. Saharsh Davuluri will assume the role ...
PharmiWeb

Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that data ...
PharmiWeb

ESCMID Global 2026: Shionogi presents new real-world data highlighting clinical effectiveness of Fetroja®/Fetcroja® (cefiderocol) in MBL-producing Enterobacterales infections

Real world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase ...